• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-27

  Oliveira et al. report that naturally occurring angiotensin fragments can increase the binding of SARS-CoV-2 spike protein to host-cell receptors, with the strongest activity observed for shorter, N-terminally truncated peptides. The study identifies peptide structure, especially modifications around tyrosine, as a potential determinant of spike–receptor interactions while also highlighting the need for cellular and in vivo validation.

• S63845 MCL1 Inhibitor: Apoptosis Workflow

  2026-08-27

  S63845 provides a selective way to test whether cancer cells depend on MCL1-mediated restraint of mitochondrial apoptosis. This workflow combines dose-response profiling with BAX/BAK, cytochrome c, caspase, PARP, and LACTB-aware readouts to distinguish pathway engagement from nonspecific toxicity.

• Captopril ACE Inhibitor: Workflows & Troubleshooting

  2026-08-26

  Captopril supports reproducible ACE inhibition in hypertension research while offering a practical probe for apoptosis induction in cancer cells and peptide-mediated gastrointestinal assays. This guide connects concentration planning, Angiotensin I-versus-II controls, and bradykinin B2 receptor experiments without overstating what the reference study directly demonstrated.

• BAPTA-AM: Calcium Chelation Workflows

  2026-08-26

  BAPTA-AM provides a practical way to test whether intracellular Ca²⁺ is a driver rather than a bystander in neuronal injury, apoptosis, and channel physiology. This guide combines concentration-controlled loading, calcium imaging, pathway-level validation, and troubleshooting for more interpretable experiments.

• Berbamine hydrochloride: NF-κB Assay Workflows

  2026-08-25

  Berbamine hydrochloride supports phenotype-to-mechanism workflows that connect viability, STAT3, calcium homeostasis, NF-κB signaling, and ferroptosis-related readouts. This guide shows how to use it as a carefully controlled perturbation tool in leukemia and hepatocellular carcinoma models without overstating pathway selectivity.

• Diminazene Aceturate: A Two-Axis Research Framework

  2026-08-25

  Diminazene Aceturate is a trypanocidal research compound with applications spanning parasite assays and ACE2 activation research. This guide develops an assay-centered framework for interpreting its chemistry, mitochondrial findings, controls, and experimental limitations.

• BFH772 (VEGFR2 inhibitor): Workflow Guide

  2026-08-24

  BFH772 provides a selective small-molecule tool for testing VEGFR2-dependent signaling and angiogenesis-related responses without treating the compound as a broad-spectrum kinase inhibitor. It is appropriate for controlled biochemical, cellular, and tumor angiogenesis research, but its water insolubility and limited directly matched paper evidence require careful formulation, vehicle controls, and assay-specific validation.

• ARB Remodeling of Cold Tumors and ICB Response

  2026-08-24

  The 2024 Journal for ImmunoTherapy of Cancer study identifies AGTR1 as a therapeutic vulnerability in collagen-rich, immune-excluded armored and cold tumors. Its evidence indicates that angiotensin receptor blockade acts chiefly through cancer-associated fibroblasts, reducing type I collagen and improving response to immune checkpoint blockade, with supportive multicenter cohort and meta-analytic findings.

• AG-120 (Ivosidenib) | IDH1 Inhibitor

  2026-08-23

  A scenario-based guide to using AG-120 (Ivosidenib), mutant IDH1 inhibitor (SKU B7805), in viability, proliferation, and differentiation assays. The article connects 2-hydroxyglutarate reduction with practical controls, stock preparation, interpretation, and vendor-selection criteria.

• Diminazene Aceturate: Research Workflows

  2026-08-22

  Diminazene Aceturate supports both trypanosome parasite research and mechanistic studies of ACE2-linked mitochondrial biology. This workflow-focused guide covers solution preparation, assay design, cross-domain applications, and troubleshooting while keeping pharmacological findings separate from proposed optimization steps.

• Homoharringtonine: Mechanism and Research Evidence

  2026-08-22

  Homoharringtonine is a cytotoxic alkaloid and protein synthesis inhibitor used in leukemia research and cancer biology. Peer-reviewed evidence also reports nanomolar SARS-CoV-2 inhibition, animal clearance, and exploratory human nasal-delivery findings, but these results do not establish a general medical treatment.

• Lenalidomide (CC-5013) in Myeloma Research

  2026-08-21

  Lenalidomide (CC-5013) supports multiple myeloma research through coordinated immune activation, TNF-alpha suppression, and anti-angiogenic activity. This workflow translates recent DOT1L–innate immunity findings into practical combination assays, readout selection, and troubleshooting decisions.

• CD28–ARS2 Control of CD8+ T-Cell Metabolism

  2026-08-20

  The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM and promotes metabolic flexibility in activated CD8+ T cells. Its findings connect PKM2-biased splicing with glucose utilization, interferon-γ production, and antitumor activity, while showing that this metabolic program can operate independently of CD28-driven PI3K signaling.

• Necrosulfonamide in Necroptosis Assay Design

  2026-08-20

  Necrosulfonamide enables mechanism-resolved testing of MLKL-dependent membrane failure rather than simply measuring cell loss. This guide translates recent cardiac microvascular ischemia–reperfusion findings into practical NSA workflows for necroptosis assays, cancer research, and pathway troubleshooting.

• Müller Cell PEDF Controls Angiopoietin-Linked Survival

  2026-08-19

  The 2026 reference study identifies Müller cells as an active intermediary between angiopoietin signaling and retinal neuronal survival. Its experiments show that Ang-1 and Ang-2 exert opposing effects through Tie-2/PI3K/Akt regulation of pigment epithelium-derived factor, providing a mechanistic framework for studying neurovascular dysfunction in hypoxic retina.

7720 records 1/515 page Next 12345 下5页 Last page